Can-Fite BioPharma Ltd. (TASE:CFBI) US subsidiary OpththaliX Inc. (Bulletin Board: OPLI), which handles the company’s ophthalmic drug development operations, today announced success in the preclinical trial of CF101 for the treatment of anterior uveitis, an inflammation of the uvea, the middle layer of the eye which can result in blindness.
ScienceDaily (Apr.
SAN FRANCISCO, CA–(Marketwire -04/10/12)- April is National Minority Health Month and, as with many health concerns, minority populations are at a greater risk for eye disease and visual impairment. For example, glaucoma is a leading cause of blindness among African Americans and Hispanics in the U.S. Three times as many African Americans have glaucoma than Caucasians, and four times as many are blind.(1) EyeCare America, a public service program of the Foundation of the American Academy of Ophthalmology, wants to improve access to care for underserved communities by offering free or no out-of-pocket cost eye exams to qualifying individuals.
While the wine inside the bottle remains the same popular red blend as always, the label has been subtly adjusted. Working with latest digital pigmentation technologies and research from London’s Applied Vision Research Centre, the new label allows colour-blind people to see exactly the same label as people without a colour vision deficiency
The underwater horror game Deep Sea, which was on display at Game Developer Conference 2012′s Experimental Gameplay Session, is terrifying to think about, even before you put on the mask. Like the cursed videotape in The Ring and urban legends surrounding Ouija boards, Deep Sea has a way of getting inside your head
(WEAU) – “People don’t notice that my daughter is blind,” said Sharon Pfeifer, Nicoles mom.
To help the Lions Club with their projects, raising money for eyeglasses for children and for the Eye and Tissue Bank, call A.C. or Mary Beth Sharp at 325-695-1406
AHWATUKEE, AZ – Abby Crosby is just like any other 8-year-old girl, in most respects.
Public release date: 28-Mar-2012 [ | E-mail | Share ] Contact: Joana Casas mcasas@jdrf.org 212-479-7560 Juvenile Diabetes Research Foundation International iCo Therapeutics (TSX-V: ICO), a Vancouver-based drug reprofiling company and JDRF, the largest charitable funder of type 1 Diabetes (T1D) research have joined forces to investigate a potential new treatment for one of the most common complications of diabetes, diabetic macular edema (DME).
–Trial that aims to address the leading cause of blindness in people with type 1 diabetes and type 2 diabetes being led by Johns Hopkins investigators– iDEAL Phase II Study Update VANCOUVER , March 28, 2012 /CNW/ – iCo Therapeutics (TSX-V: ICO.V – News), a Vancouver-based drug reprofiling company and JDRF, the largest charitable funder of type 1 Diabetes (T1D) research have joined forces to investigate a potential new treatment for one of the most common complications of diabetes, diabetic macular edema (DME).
VANCOUVER, BRITISH COLUMBIA–(Marketwire -03/28/12)- Seva Canada, a Canadian eye care charity based in Vancouver, turns 30 on April 6! Since 1982, Seva Canada has restored sight and prevented blindness in the developing world, giving the power of sight to over 3 million of the world’s poorest people. But what makes Seva different and effective is its unique approach to international development, empowering the people and communities where it works.
TARPON SPRINGS, FL–(Marketwire -03/27/12)- Dr. Edward Huggett today announced that he is now offering ChromaGen lenses at his Tarpon Springs location. ChromaGen is a life changing aid for visual reading disorders often associated with dyslexia and optical corrective solution for color deficiency, which is also known as color blindness
Urban Miyares is 64-years-old and is living proof that you can overcome any obstacle. “If you were given a death sentence and you only had a year to live, or 10, or 20, I am sure you would change your life too, he said.
BY SUSAN DEMAR LAFFERTY slafferty@southtownstar.com March 25, 2012 6:28PM Dr. Benjamin Ticho, a pediatric ophthamologist, prepares to do a photographic scan of the retinas and eyes of premature baby, Alyssa Smith, at Advocate Christ Medical Center in Oak Lawn Thursday, March 22, 2012.
COCONUT CREEK The gymnasium was full of men grappling, flipping and twisting over each other, each seemingly with the same goal of inflicting pain.
A young boy prepared his beloved pony for experimental surgery on Friday. Nathan Young received Buggs on his first birthday present, 10TV’s Andrea Cambern reported. “My mom put a little saddle on him.
HuffPost’s QuickRead… Loading…
By Galina Stolyarova The St. Petersburg Times Published: March 21, 2012 (Issue # 1700) Are you willing to spend ten minutes to put yourself in the shoes of someone who has almost lost the ability to see? This was the question faced by lawmakers from the St
LANSING People suffering from glaucoma would no longer be allowed to legally use marijuana to treat the condition according to a bill that cleared a state Senate committee on Tuesday. But medical marijuana advocates say the drug helps slow symptoms of the eye condition and possibly prevent or delay blindness. The bill, supported by several doctors and medical associations, was approved by the Senate Judiciary Committee by a 3-0 vote, with Sen
HuffPost’s QuickRead… Loading… HuffPost’s QuickRead…